Suppr超能文献

甲状腺毒症¹³¹I治疗后促甲状腺激素释放激素和三碘甲状腺原氨酸抑制试验(作者译)

[TRH and T3 suppression tests after 131I therapy of thyrotoxicosis (author's transl)].

作者信息

Tamai H, Tsushimi T, Shizume K, Kuma K, Suematsu H

出版信息

Nihon Naibunpi Gakkai Zasshi. 1976 Mar 20;52(3):232-42. doi: 10.1507/endocrine1927.52.3_232.

Abstract

TRH and T3 suppression tests were performed on patients (124 cases) with Graves' disease who underwent radiation therapy. TRH test was performed at 4-6 months (Group I), 6-12 months (Group II), 12-24 months (Group III) and 24-50 months (Group IV) after final radiation therapy, and T3 suppression test was performed just after each TRH test. The response to TRH test was defined as positive when the basal TSH value was less than 2.0 muU/ml and the peak value was more than 6.2 muU/ml following TRH (500 mug) injection. T3 suppression test was performed by measuring the 24-hr thyroidal uptake of radioiodine after daily administration of 75 mug of T3 for 8 days. The response was defined as positive when the value for 24-hr uptake after T3 administration was less than half of the control value. The results were as follows; 1) Among 124 patients in Group I to IV who were clinically euthyroid and whose T3-RU and T4 values were normal, compared with other groups, Group IV (2-4.2Y) showed a significantly higher percentage of positive responses to both TRH and T3 suppression tests. However, among 49 of 124 patients whose T3 was also normal, there were no significant differences between the groups. 2) The value of triiodothyronine was above the normal range in many cases up to 2 years after radiation therapy (in Group I, II, III). 3) There were no significant differences in the percentage of hyperresponses between any of the four groups. Half of the patients who showed positive responses to TRH test showed exaggerated responses. 4) In all cases when the responses to TRH and T3 suppression tests changed from negative to positive, thyroxine and triiodothyronine concentrations must be within the normal range. In particular, the major determinant seems to be the value of triiodothyronine. 5) As in more than 30% of cases TRH and T3 supression tests changed from negative to positive, thyroxine and triiodothyronine concentrations must be within the normal range. In particular, the major determinant seems to be the value of triiodothyronine. 5) As in more than 30% of cases TRH and T3 suppression tests remained negative even though their T3-RU, T4, T3, values became normal after radiation therapy, the regulation of hypothalamo-hypophyseal thyroid axis do not always return to normal even though circulating thyroidal hormone level return to an euthyroid state.

摘要

对接受放射治疗的124例格雷夫斯病患者进行了促甲状腺激素释放激素(TRH)和三碘甲状腺原氨酸(T3)抑制试验。TRH试验在最终放射治疗后的4 - 6个月(I组)、6 - 12个月(II组)、12 - 24个月(III组)和24 - 50个月(IV组)进行,并且每次TRH试验后紧接着进行T3抑制试验。当基础促甲状腺激素(TSH)值小于2.0微单位/毫升且在注射TRH(500微克)后峰值大于6.2微单位/毫升时,TRH试验的反应被定义为阳性。T3抑制试验通过在每天给予75微克T3共8天后测量24小时甲状腺对放射性碘的摄取来进行。当给予T3后24小时摄取值小于对照值的一半时,反应被定义为阳性。结果如下:1)在I至IV组的124例临床甲状腺功能正常且其三碘甲状腺原氨酸摄取率(T3 - RU)和甲状腺素(T4)值正常的患者中,与其他组相比,IV组(2 - 4.2岁)对TRH和T3抑制试验的阳性反应百分比显著更高。然而,在124例T3也正常的患者中的49例中,各组之间无显著差异。2)放射治疗后长达2年,许多病例中的三碘甲状腺原氨酸值高于正常范围(I组、II组、III组)。3)四组中任何一组的高反应百分比均无显著差异。对TRH试验呈阳性反应的患者中有一半表现出过度反应。4)在所有TRH和T3抑制试验反应从阴性变为阳性的病例中,甲状腺素和三碘甲状腺原氨酸浓度必须在正常范围内。特别是,主要决定因素似乎是三碘甲状腺原氨酸的值。5)由于超过30%的病例中TRH和T3抑制试验从阴性变为阳性,甲状腺素和三碘甲状腺原氨酸浓度必须在正常范围内。特别是,主要决定因素似乎是三碘甲状腺原氨酸的值。5)由于超过30%的病例中,即使放射治疗后其T3 - RU、T4、T3值恢复正常,TRH和T3抑制试验仍保持阴性,因此即使循环甲状腺激素水平恢复到甲状腺功能正常状态,下丘脑 - 垂体 - 甲状腺轴的调节并不总是恢复正常。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验